Clinical Trial Update: Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update examining the effect of a nitric oxide donor on endothelial progenitor cells in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Nitric Oxide Donor

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED